Bora Pharmaceuticals Co., Ltd./ADR (BORAY) Executive Compensation
Access SEC EDGAR filings, financial statements, 10-K, 10-Q, 8-K reports, auditor information, and financial intelligence for Bora Pharmaceuticals Co., Ltd./ADR (BORAY).
Ticker: BORAY
CIK: 2097461
Exchange: OTC
Fiscal Year End: 12/31
State: F5
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PCAOB Registered Accounting Firm
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2025-12-15 | — | EFFECT Filing | 9999999995-25-003738 | View SEC Doc Filr Page |
| F-6 | 2025-11-24 | — | F-6 Filing | 0001193805-25-001642 | View SEC Doc Filr Page |